With support from Donghai Securities (Donghai), one of China's most successful investment banks, and the German Startups Group, an investment company headquartered in Berlin and focusing on young, rapidly growing businesses, Fiagon AG has been able to increase its investment budget by another 7.5 million euros.
The decision was surely not a difficult one for investors to make, since Fiagon AG was able to recently increase revenue by more than 5 million euros and successfully conclude the fiscal year. Business is expected to continue on this ambitious path.
Fiagon AG is not only inspiring renowned investors with the navigation technology but is also making an important contribution to patient safety during complex surgical interventions.
Dr. Timo Krüger (CEO): "Thanks to our new investors, we will not only continue our growth course but also be able to focus on the placement of disposables on the U.S. and Chinese market.
With navigated instruments for single use, we are planning to not only strategically expand our product portfolio but also to develop additional market potentials at the same time. With moderate but steady steps, we are developing into a major player on the international market. Along with the increase in capital, we have decided to simultaneously expand our strategic competence in our supervisory board. I am delighted to welcome three new board members to Fiagon AG."
1. Dr. Olaf Schermeier, member of the executive board of Fresenius Medical Care AG & Co. KGaA
Dr. Olaf Schermeier: "The navigation technology of Fiagon AG has the potential to set new standards in surgical navigation. I am looking forward to providing the management team with support in the next phase of growth."
2. Dr. Clemens Scholz, Chief Executive of World of Medicine GmbH
Dr. Clemens Scholz: "Complex surgical procedures on the head or spine are a very stressful situation for patients. With this technology, we would like to ensure that each patient simultaneously receives the best possible technical treatment combined with the lowest risks. Here, the surgeon is supported not only in performing but also in planning surgical interventions. In this way, the navigation helps the surgeon during detailed planning to identify and mark high-risk structures in the tissue, such as nerves and blood vessels, and to also protect these structures during the intervention. We are delighted with Fiagon AG's outstanding success and wish them continued success."
3. Mr. Hua (Alex) Liu, General Manager International, Business Department Donghai Securities Ltd.
Hua (Alex) Liu: "Fiagon, with its state-of-the-art technology, fits precisely in the focus of Donghai, which concentrates on Life Sciences and Cleantech, Internet of Things (IOT) and Industry 4.0. With Donghai’s commitment, Fiagon strengthens its solid financial basis for continuing its pursuit of a growth-oriented corporate strategy. Donghai is delighted to support Fiagon in its production establishment, growing their network and giving guidance in one of the world's most important sales markets.”
The success story of Fiagon AG is based not merely on the idea of the company founders Dr. Timo Krüger (CEO) and Dr. Dirk Mucha (CTO) for visualizing hidden structures in the human body (particularly in the head and spine) and make them accessible for surgical interventions. The objective is to turn modern navigation technology into the standard (state of the art) of interventional medical facilities.
The decision was surely not a difficult one for investors to make, since Fiagon AG was able to recently increase revenue by more than 5 million euros and successfully conclude the fiscal year. Business is expected to continue on this ambitious path.
Fiagon AG is not only inspiring renowned investors with the navigation technology but is also making an important contribution to patient safety during complex surgical interventions.
Dr. Timo Krüger (CEO): "Thanks to our new investors, we will not only continue our growth course but also be able to focus on the placement of disposables on the U.S. and Chinese market.
With navigated instruments for single use, we are planning to not only strategically expand our product portfolio but also to develop additional market potentials at the same time. With moderate but steady steps, we are developing into a major player on the international market. Along with the increase in capital, we have decided to simultaneously expand our strategic competence in our supervisory board. I am delighted to welcome three new board members to Fiagon AG."
1. Dr. Olaf Schermeier, member of the executive board of Fresenius Medical Care AG & Co. KGaA
Dr. Olaf Schermeier: "The navigation technology of Fiagon AG has the potential to set new standards in surgical navigation. I am looking forward to providing the management team with support in the next phase of growth."
2. Dr. Clemens Scholz, Chief Executive of World of Medicine GmbH
Dr. Clemens Scholz: "Complex surgical procedures on the head or spine are a very stressful situation for patients. With this technology, we would like to ensure that each patient simultaneously receives the best possible technical treatment combined with the lowest risks. Here, the surgeon is supported not only in performing but also in planning surgical interventions. In this way, the navigation helps the surgeon during detailed planning to identify and mark high-risk structures in the tissue, such as nerves and blood vessels, and to also protect these structures during the intervention. We are delighted with Fiagon AG's outstanding success and wish them continued success."
3. Mr. Hua (Alex) Liu, General Manager International, Business Department Donghai Securities Ltd.
Hua (Alex) Liu: "Fiagon, with its state-of-the-art technology, fits precisely in the focus of Donghai, which concentrates on Life Sciences and Cleantech, Internet of Things (IOT) and Industry 4.0. With Donghai’s commitment, Fiagon strengthens its solid financial basis for continuing its pursuit of a growth-oriented corporate strategy. Donghai is delighted to support Fiagon in its production establishment, growing their network and giving guidance in one of the world's most important sales markets.”
The success story of Fiagon AG is based not merely on the idea of the company founders Dr. Timo Krüger (CEO) and Dr. Dirk Mucha (CTO) for visualizing hidden structures in the human body (particularly in the head and spine) and make them accessible for surgical interventions. The objective is to turn modern navigation technology into the standard (state of the art) of interventional medical facilities.
